IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    Best solo travel destinations to visit in 2024: Portland, Dallas, more

    03:36
  • 11-year-old advocates to get gluten labeled as an allergen in US

    06:04
  • Laurie Hernandez on who to watch in Olympic gymnastics qualifier

    04:02
  • How to figure out how much you need to save for retirement

    04:20
  • Shop these apps and gadgets geared toward improving health

    04:21
  • Tavia Hunt, wife of Chiefs’ CEO, responds to Harrison Butker’s speech

    02:49
  • How to know if an online retail site is reputable

    04:06
  • Police detain golfer Scottie Scheffler outside PGA Championship

    00:28
  • North Korea test-fires suspected short-range missiles off its coast

    00:26
  • Simone Biles, Gabby Douglas compete for spot on Team USA

    03:16
  • Dow crosses above 40,0000 for the first time: Is it just symbolic?

    01:37
  • US aid arrives in Gaza but protesters block or attack some convoys

    02:04
  • Justice Alito responds to upside-down US flag on his front lawn

    00:52
  • Trump defense tries to portray Michael Cohen as a serial liar

    02:45
  • Hearing on Biden special counsel interview spurs personal attacks

    02:27
  • At least 4 killed around Houston after severe weather, flooding

    02:56
  • Hoda and Jenna react to Harrison Butker’s commencement speech

    05:09
  • STEM high school students take soccer to the air – with drones!

    04:24
  • Al Roker honored for shining a light on national parks

    02:29
  • Uber offers new services for caregivers: Here's how it works

    03:04

‘We have every tool we need to put this pandemic behind us,’ doctor says

03:29

Dr. Ashish Jha, dean of Brown University’s school of public health, joins TODAY to discuss the latest developments on the omicron variant. He calls Pfizer’s new anti-viral pill another great tool to help stop the spread of the coronavirus, but says it may take time to overcome other issues like supply shortages and misinformation.